Evaluation of a Peer Recovery Support Program Adapted to Target Retention in Clinic-based Medication for Opioid Use Disorder Treatment
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 218
- 试验地点
- 1
- 主要终点
- Length of time in treatment
研究概览
简要总结
The goal of this clinical trial is to learn if receiving peer recovery support (support services provided by trained "peers" with lived experience of addiction and recovery) improves retention in medication treatment among people with opioid use disorder. The main question it aims to answer is: does peer recovery support improve retention in medication treatment for opioid use disorder?
Researchers will compare two groups: (1) standard care combined with a peer recovery support program, and (2) standard care alone, to see if peer recovery support works to improve retention in medication treatment for opioid use disorder.
Participants will: visit clinics as they normally would to receive standard care (medication treatment for opioid use disorder); complete two questionnaires - one when they start treatment and one 6 months later; and agree to let researchers use information from their medical record. Participants in group 1 will also be invited to meet with a peer recovery support specialist for up to 6 months.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 89 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult ≥ 18 years of age
- •Initiated medication for opioid use disorder treatment in past 45 days in a Geisinger outpatient clinic
- •Willing and able to give informed consent
排除标准
- •Received medication for opioid use disorder treatment at a Geisinger outpatient clinic in the 90-day period prior to the treatment initiation date
- •Not proficient in English
研究组 & 干预措施
Standard Care
Study participants will receive the standard care - medication treatment for opioid use disorder
Standard Care + Peer Recovery Support
In addition to standard care (medication treatment for opioid use disorder), study participants will receive support provided by a peer recovery support specialist
干预措施: Peer recovery support to enhance patient engagement in medication for opioid use disorder treatment (Behavioral)
结局指标
主要结局
Length of time in treatment
时间窗: 180 days from initiation of medication treatment for opioid use disorder
Data will come from the electronic health records. Length of time in treatment will be determined by summing days' supply of consecutive orders for medications for opioid use disorder treatment(buprenorphine, buprenorphine- naloxone, or naltrexone). Treatment will be considered ended if a participant has a gap in supply of more than 30 days.
6-month treatment retention
时间窗: 180 days from initiation of medication treatment for opioid use disorder
Data will come from the electronic health records. Retention will be defined as a participant not having a lapse in days' supply of medication for opioid use disorder treatment (buprenorphine, buprenorphine-naloxone, or naltrexone) within the 6-month follow-up period that is greater than 30 days.
次要结局
未报告次要终点
研究者
Melissa Poulsen
Associate Professor
Geisinger Clinic